GRANT ROUND UP 11/19/24-11/25/24

Posted by on

DOC-DOCNOAAERA Sea Grant Programs Only - FY2025 Aquaculture Legal, Regulatory, and Policy Grants NOAA-OAR-SG-2025-29312
  National Estuarine Research Reserve System (NERRS) Land Acquisition and Construction Program for Fiscal Year 2025 NOAA-NOS-OCM-2025-29258
  FY25 Pacific Islands - Hawai'i Marine Wildlife Response and Outreach NOAA-NMFS-PIR-2025-29385
  FY2025 NMFS-Sea Grant Fellowship in Population and Ecosystem Dynamics and Marine Resource Economics NOAA-OAR-SG-2025-29114
DOD-AMRAA DOD Glioblastoma, Transformative Consortium Award HT942524GBMRPTCA
DOE-ID FY 2025 University Nuclear Research Infrastructure Revitalization DE-FOA-0003314
  High-Assay Low-Enriched Uranium (HALEU) Transportation Package, Inflation Reduction Act (IRA) DE-FOA-0002967
DOI-BOR Native American Affairs: Technical Assistance to Tribes for Fiscal Year 2025 R25AS00016
DOS-ALB Cultural Property Agreement Implementation Grant (CPAIG) Program – Albania CPAIG-TIRANA-2025
DOS-ARM U.S. Embassy Yerevan PDS Annual Program Statement PDS-APS-FY25-02
DOS-BFA U.S. Embassy BURKINA FASO PDS Annual Program Statement PAS-BF-FY25-APS-001
  Alumni Engagement Innovation Fund 2025 2025-BF-AEIF
DOS-BLZ Building Stronger Governance through Civil Society Engagement BH20024GR200WHA
DOS-CZE Embassy Prague PDS Annual Program Statement 2025 PAS-001-FY2025
DOS-DEU FY25 Alumni Engagement Innovation Fund DOS-DEU-PD-NOFO-25101
DOS-ECA FY25 Cultural Property Agreement Implementation Grants CPAIG2025
DOS-ETH Alumni Engagement Innovation Fund (AEIF) 2025 PDS-001-FY2025
DOS-INL Recommendations To Increase Successful Utilization of Alternative Dispute Resolution (ADR) in Bosnia and Herzegovina OFOP0001662
DOS-LBN Alumni Engagement Innovation Fund - Lebanon 2025 LBN-PDS-2025-AEIF
  Ambassadors Fund for Cultural Preservation - Lebanon 2025 LBN-PDS-2025-AFCP
DOS-NAM FY 2025 U.S. Study Abroad Engagement Grants WHK-STUDYABROAD-FY25-02
DOS-SVK U.S. Embassy Bratislava PAS, AEIF 2025 PAS-SVK-FY2025-01
DOS-ZAM Ambassadors Fund for Cultural Preservation 2025 Grants Program PD-LUSAKA-AFCP-FY2025
ED Office of Elementary and Secondary Education (OESE): Office of Indian Education (OIE) Formula Grants to Local Educational Agencies, Assistance Listing Number (ALN) number 84.060A ED-GRANTS-112524-001
  Office of Postsecondary Education (OPE): Student Support Service: Gaining Early Awareness and Readiness for Undergraduate Programs (GEAR UP) Partnership Grants, Assistance Listing Number 84.334A ED-GRANTS-112024-001
  Office of Postsecondary Education (OPE): Student Support Service: Gaining Early Awareness and Readiness for Undergraduate Programs (GEAR UP) State Grants, Assistance Listing Number 84.334S ED-GRANTS-112024-002
HHS-ACF-OHS Tribal Colleges and Universities Head Start Partnership Program Grants HHS-2025-ACF-OHS-YT-R11-0156
  American Indian and Alaska Native Head Start Expansion, Early Head Start Expansion, and Early Head Start-Child Care Partnership Grants HHS-2025-ACF-OHS-HI-0066
HHS-CDC-HHSCDCERA Occupational Safety and Health Training Project Grants (T03) RFA-OH-25-003
HHS-HRSA Scholarships for Disadvantaged Students HRSA-25-076
  Pediatric Pulmonary Centers Program HRSA-25-026
HHS-IHS Tribal Management Grant Program HHS-2025-IHS-TMD-0001
HHS-NIH11 Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) PAR-25-291
  Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) RFA-HL-26-016
  Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed) RFA-AI-24-076
  Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-25-171
  Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) RFA-HL-26-017
  Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) RFA-HL-26-018
  Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) RFA-HL-26-019
  Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) RFA-HL-26-020
  Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) PAR-25-282
  Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) PAR-25-281
  Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) PAR-25-290
  Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) PAR-25-106
  Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) PAR-25-107
  Co-infection and Cancer (R01 Clinical Trial Not Allowed) PAR-25-082
  Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) PAS-25-190
  Co-infection and Cancer (R21 Clinical Trial Not Allowed) PAR-25-083
  Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional) PAR-25-278
  BRAIN Initiative: Promoting Equity Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed) RFA-NS-25-016
  Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) PAR-26-001
  Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-25-148
  Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) PAR-25-035
  Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) PAR-25-235
  Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R21 Clinical Trial Not Allowed) RFA-MH-26-111
  Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R01 Clinical Trial Not Allowed) RFA-MH-26-110
  NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) PAR-25-261
  NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) PAR-25-267
  Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R43 - Clinical Trials Optional) RFA-DA-26-016
  Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R41 - Clinical Trials Optional) RFA-DA-26-017
  NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed) RFA-NR-25-002
  Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed) RFA-NS-25-027
  Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) PAR-25-274
  Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) PAR-25-268
  Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) PAR-25-254
  NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program (R25 Clinical Trial Not Allowed) PAR-24-290
  Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) PAR-25-287
  Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) PAR-25-286
  Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) PA-25-295
  Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) PA-25-294
  Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) RFA-DA-26-034
  Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) PAR-25-217
  Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) PAR-25-220
  NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) PAR-25-135
  Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed) RFA-HG-25-004
  Advancing Genomic Medicine Research (R01 Clinical Trial Optional) RFA-HG-25-002
  Advancing Genomic Medicine Research (R21 Clinical Trial Optional) RFA-HG-25-003
  Biology of Bladder Cancer (R01 Clinical Trial Optional) PAR-25-129
  Biology of Bladder Cancer (R21 Clinical Trial Optional) PAR-25-128
NASA-HQ ROSES 2024: A.62 FarmFlux Science Team NNH24ZDA001N-FFST
  ROSES 2024: F.11 Payloads and Research Investigations on the Surface of the Moon: Stand-Alone Landing Site-Agnostic NNH24ZDA001N-PSALSA
NEH Institutes for Higher Education Faculty and K-12 Educators 20250212-EH-ES
NSF Experiential Learning for Emerging and Novel Technologies 25-511
USDA-FS Community Wildfire Defense Grant 2024 (FY25) Northeast-Midwest USDA-FS-2024-CWDG-NEMW
  Community Wildfire Defense Grant 2024 (FY25) South USDA-FS-2024-CWDG-SGSF
  Community Wildfire Defense Grant 2024 (FY25) West USDA-FS-2024-CWDG-CWSF
  Community Wildfire Defense Grant 2024 (FY25) Tribes USDA-FS-2024-CWDG-TRIBES

← Older Post



Leave a comment

Please note, comments must be approved before they are published